Novo Nordisk Total Non-Operating Income/Expense 2010-2024 | NVO
Novo Nordisk total non-operating income/expense for the twelve months ending December 31, 2024 was $-0.166B, a 154.59% decline year-over-year.
- Novo Nordisk annual total non-operating income/expense for 2024 was $-0.166B, a 154.59% decline from 2023.
- Novo Nordisk annual total non-operating income/expense for 2023 was $0.305B, a 137.47% decline from 2022.
- Novo Nordisk annual total non-operating income/expense for 2022 was $-0.814B, a 1273.13% decline from 2021.